arrow
Back
I

Istituto Di Ematologia Seragnoli

Scholars36
Papers10
Citations0
Related Papers (10)
Publication Date
Advancing chemogenomic strategies for functional precision medicine in relapsed-refractory T-ALL and ETP-ALL: the GIMEMA ALL2720 trial
err2026-08-12
err0
errOAAI
errLuca Pagliaro; Roberto Rosati; Mariateresa Giaimo; Valentina Bardelli; Raffaella Zamponi; Katia Tragni; Anna Montanaro; Andrea Gherli; Monica Messina; Alfonso Piciocchi; Giovanni Marsili; Enrico Crea; Paola Fazi; Marco Vignetti; Cristina Papayannidis; Fabio Giglio; Benedetta Cambò; Sabina Chiaretti; Matteo Piccini; Federico Lussana; Simona Sica; Patrizia Zappasodi; Lorenzo Brunetti; Eloise Beggiato; Ernesta Audisio; Erika Borlenghi; Monica Bocchia; Renato Bassan; Mariangela Di Trani; Anna Pessina; Amelia Rinaldi; Lucia Prezioso; Roberta La Starza; Cristina Mecucci; Giovanni Roti
errShare
errSave
Automated Deauville Score computation from baseline [¹⁸F]FDG PET/CT predicts progression-free survival in multiple myeloma: a radiogenomic framework
err2026-07-30
err0
errOAAI
errSara Peluso; Stefano Polizzi; Lisa Pagnini; Martina Tarozzi; Ettore Rocchi; Valentino Dragonetti; Vincenza Solli; Daniele Dall’Olio; Marco Talarico; Carolina Terragna; Claudia Sala; Elena Zamagni; Stefano Fanti; Cristina Nanni; Gastone Castellani
errShare
errSave
Transition from inpatient to outpatient step-up dosing of bispecific antibodies in multiple myeloma: real-world insights
err2026-07-23
err0
errOAAI
errEnrica Manzato; Michele Puppi; Simona Barbato; Alessandra Vitale; Ilaria Sacchetti; Simone Masci; Roberta Restuccia; Stefano Ghibellini; Lucia Pantani; Katia Mancuso; Ilaria Rizzello; Marco Talarico; Gloria Cocchetto; Chiara Terreo; Miriam Iezza; Michele Cavo; Elena Zamagni; Paola Tacchetti
errShare
errSave
Dynamics of IDH1/2 mutated clones in acute myeloid leukemia challenge their use as universal MRD markers
err2026-06-30
err0
errOAAI
errGiovanni Marconi; Lorenza Bandini; Agnese Patuelli; Valentina Robustelli; Claudia Venturi; Giorgia Simonetti; Jacopo Nanni; Gianluca Cristiano; Chiara Sartor; Michela Rondoni; Cristina Papayannidis; Francesco Lanza; Emanuela Ottaviani; Antonio Curti
errShare
errSave
Long-term follow-up of the transplant-eligible cohort of the EMN12/HOVON-129 study for primary plasma cell leukemia patients
err2026-06-24
err0
errOAAI
errNiels W. C. J. van de Donk; Fredrik Schjesvold; Bronno van der Holt; Monique C. Minnema; Ka Lung Wu; Annemiek Broijl; Wilfried W. H. Roeloffzen; Alain Gadisseur; Giuseppe Pietrantuono; Ludek Pour; Vincent H. J. van der Velden; Thomas Lund; Massimo Offidani; Sara Bringhen; Luisa Giaccone; Wida Razawy; Paola Tacchetti; Katia Mancuso; Trine Silkjaer; Jo Caers; Sonja Zweegman; Roman Hájek; Reuben Benjamin; Annette Juul Vangsted; Mario Boccadoro; Francesca Gay; Pieter Sonneveld; Pellegrino Musto
errShare
errSave
Isatuximab, carfilzomib, lenalidomide and dexamethasone in newly diagnosed multiple myeloma: a randomized phase 3 trial
err2026-04-06
err0
errOAAI
errFrancesca Gay; Wilfried Roeloffzen; Meletios A. Dimopoulos; Laura Rosiñol; Marjolein van der Klift; Roberto Mina; Albert Oriol; Eirini Katodritou; Ka Lung Wu; Paula Rodríguez Otero; Roman Hájek; Elisabetta Antonioli; Mark van Duin; Mattia D’Agostino; Joaquín Martínez-López; Elena M. van Leeuwen-Segarceanu; Elena Zamagni; Niels W. C. J. van de Donk; Katja C. Weisel; Luděk Pour; Jakub Radocha; Angelo Belotti; Fredrik Schjesvold; Joan Bladé; Hermann Einsele; Pieter Sonneveld; Mario Boccadoro; Annemiek Broijl
errShare
errSave
Comparative efficacy of zanubrutinib plus obinutuzumab versus last prior treatment in relapsed/refractory follicular lymphoma: growth modulation index analysis from the ROSEWOOD study☆
err2026-03-31
err0
errOAAI
errJ. Trotman; K. Bouabdallah; F. Bijou; D. Šálek; A.C. de Oliveira; Y. Song; E.C. Kingsley; C.R. Flowers; S. Liao; S. Huang; N. Shah; L. Dumartin; P.L. Zinzani
errShare
errSave
Development of a prognostic scoring system for chronic myeloid leukemia in blast phase
errLeukemia
IF13.4
err2026-02-19
err0
errOAAI
errMichael Lauseker; Tomasz Sacha; Hana Klamova; Julia Yakoleva; Elza Lomaia; Dragana Milojkovic; Christian Fabisch; Franck E. Nicolini; Ulla Olsson-Stromberg; Daniela Zackova; Krzysztof Lewandowski; Philipp Ernst; Fausto Castagnetti; Klaus Hirschbühl; Irena Zupan; Astghik Voskanyan; Aleksandra Gołos; Jochen J. Frietsch; Justyna Gil; Edgar Faber; Stefan W. Krause; Anne Parry; Susanne Saussele; Sonja Heibl; Georg-Nikolaus Franke; Luis Felipe Casado; Edyta Paczkowska; Holger Hebart; Matthias Eder; Peter Anhut; Karolin Trautmann-Grill; Elzbieta Szczepanek; Thomas Südhoff; Elzbieta Patkowska; Alexander Kiani; Thomas Ernst; Jane Apperley; Jiri Mayer; Andreas Hochhaus; Markus Pfirrmann; Annamaria Brioli
errShare
errSave
Correction: Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years’ follow-up
err2026-01-28
err0
errOAAI
errEva Domingo-Domènech; Barbara Pro; Tim Illidge; Steven Horwitz; Lorenz Trumper; Swami Iyer; Ranjana Advani; Nancy L. Bartlett; Jacob Haaber Christensen; Won-Seog Kim; Tatyana Feldman; Ilseung Choi; Giuseppe Gritti; David Belada; Andrei Shustov; Arpad Illes; Pier Luigi Zinzani; Andreas Hüttmann; Marek Trneny; Steven Le Gouill; Deepa Jagadeesh; Jonathan W. Friedberg; Meredith Little; Cassie Dong; Michelle Fanale; Keenan Fenton; Kerry J. Savage
errShare
errSave
Neutrophil to lymphocyte ratio at diagnosis predicts venous thrombosis in prefibrotic primary myelofibrosis: results from a multicenter cooperative study
err2026-01-15
err0
errOAAI
errFabrizio Cavalca; Roberto Latagliata; Novella Pugliese; Giuseppe Alberto Palumbo; Nicola Polverelli; Pellegrino Musto; Giulia Benevolo; Filippo Branzanti; Ambra Di Veroli; Eugenia Accorsi Buttini; Alessia Ripamonti; Ivan Civettini; Laura Montelisciani; Laura Antolini; Carlo Gambacorti-Passerini; Francesca Palandri; Elena Maria Elli
errShare
errSave